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Phosphorylation of glycogen has been known for decades; however, the basic metabolic pathways respon-
sible for this modification are unknown. In this issue, Tagliabracci et al. (2011) report the enzyme responsible
for incorporating phosphate and the chemical nature of the phosphate linkage, providing a framework for
expanding our understanding of a devastating form of epilepsy.Glycogen is a highly branched polymer of
glucose and the major storage form of
energy, from bacteria to mammals. It is
composed of glucose residues con-
nected by a-1,4-glycosidic linkages with
a-1,6-glycosidic linkages forming branch
points (Figure 1). Glycogen synthesis, in
concert with its breakdown, is of great
metabolic importance, and research in
this field has led to the discovery of
a variety of fundamental biochemical
processes. As early as 1951, McArdle
described the first glycogen storage
disease, whose hallmark was a buildup
of glycogen stores in muscle (McArdle,
1951) caused by a lack of glycogen phos-
phorylase, an enzyme that at the time was
believed to both synthesize and degrade
glycogen. This result triggered a search
for an enzyme capable of synthesizing
glycogen, and in the late 1950s, the Nobel
laureate Luis Leloir described the
synthesis of glycogen from UDP-glucose
and glycogen synthase (Leloir et al.,
1959). Since that time, many glycogen
storage diseases have been described
and the metabolic pathways responsible
for glycogen synthesis and breakdown
have been exhaustively characterized.
Nevertheless, in this issue, Tagliabracci
et al. (2011) report a new reaction carried
out by glycogen synthase that may be
a catalytic ‘‘error’’ underlying the fatal
epilepsy, Lafora disease.
Lafora disease was first described by
a student of Alois Alzheimer, Gonzalo La-
fora (Lafora, 1911). It is an autosomal
recessive neurodegenerative disorder re-
sulting in severe epilepsy and death in the
third decade. The hallmark of the disease
is the accumulation of poorly branched
insoluble carbohydrates called Lafora
bodies (LBs) that are located in the cyto-plasm of most cells (Collins et al., 1968).
LB accumulation in neurons coincides
with neuronal cell death and the number
of seizures in patients. Consequently,
LBs are hypothesized to be causative for
the disease. Characterization of LBs
demonstrates that they are composed of
glucose polymers varying from normal
glycogen in two important ways. First,
LBs have the same general composition
but contain fewer branch points, making
them more similar to the plant starch
amylopectin and rendering them insol-
uble. Second, LBs contain significantly
more covalent phosphate than normal
muscle glycogen (Tagliabracci et al.,
2007). About 50% of Lafora patients
havemutations in the EPM2A gene, which
encodes the dual-specificity phospha-
tase laforin (Minassian et al., 1998), a
glucan phosphatase that removes phos-
phate from naturally occurring carbohy-
drates and LBs (Tagliabracci et al., 2007;
Worby et al., 2006). However, ‘‘how,’’
‘‘why,’’ or ‘‘where’’ the phosphate is incor-
porated into glycogen was unknown.
These questions are addressed by Ta-
gliabracci et al. using various systems
for analyzing glycogen synthase activity
coupled with MALDI-TOF mass spectra
and nuclear magnetic resonance (NMR)
spectroscopy of purified glycogen.
The phosphate content in glycogen was
attributed to C6 monoesters and C1–C6
phosphodiesters presumably catalyzed
by an uncharacterized UDP-glucose:glyc-
ogen glucose 1-phosphotransferase that
transferred the b-phosphate of UDP-
glucose to glycogen (Lomako et al., 1993).
Tagliabracci et al. synthesized [b-32P]
UDP-glucose to assay and purify the pro-
posed UDP-glucose:glycogen glucose 1-
phosphotransferase. Unexpectedly, theyCell Metabolismobserved that a muscle extract from
a genetically modified mouse, MGSKO,
which lacks themuscle isoformofglycogen
synthase, was unable to transfer the
b-phosphate from UDP-glucose to glyco-
gen, but a corresponding wild-type mouse
muscle extract could. Similar results were
seen with a yeast knockout strain lacking
both yeast glycogen synthases (gsy1gsy2).
Indeed, with purified glycogen synthases
from multiple sources, the enzyme cata-
lyzed the time-dependent additionofphos-
phate from UDP-glucose into glycogen
at a constant relative rate with respect
to glucose incorporation. These results
pointed to glycogen synthase as the prin-
cipal enzyme responsible for thephosphor-
ylation of glycogen and the source of the
b-phosphate of UDP-glucose. Glycogen
synthase normally adds glucose residues
from UDP-glucose to the nonreducing
end of a glycogen molecule. However,
these unanticipated results suggest that
phosphate can also be introduced at
a rate of one phosphate per 10,000
glucoses by glycogen synthase. Therefore,
‘‘how’’ the phosphate is incorporated into
glycogen, i.e., the elusive glycogen
‘‘kinase’’ activity, hasfinallybeenattributed
to glycogen synthase.
This raises the question of ‘‘where’’ the
phosphate resides on glycogen which
addresses the substrate specificity of la-
forin. In a series of technically demanding
experiments, glycogen was purified from
skeletal muscle by procedures designed
to retain phosphate and was subjected
to treatment with glycogen-hydrolyzing
enzymes. The resulting phospho-oligo-
saccharides were subjected to MALDI-
TOF mass spectrometry, high-perfor-
mance anion exchange chromatography,
and NMR spectroscopy. From these13, March 2, 2011 ª2011 Elsevier Inc. 233
OO
O
OH
O
O
HO
O
HO
OH
O
OH
O
OH
O
OH
HO
HOP
O
O
-
O
-
O
1
6
5
4
3
2
O
NH
O
ON
O
OHOH
O
O
O
HO
OH
HO
HO
POP
O
O
-
O
O
-
O
O
O
OH
O
O
HO
O
HO
OH
O
OH
O
OH
O
OH
HO
HO
HO
HO
1
6
5
4
3
2
O
P
O
-
O
-
O
O
Glycogen Synthase
Laforin
UMP
Pi
UDP-glucose UDP
or
Figure 1. Incorporation of Phosphate into Glycogen
Glycogen synthase synthesizes glycogen by the sequential transfer of
a glycosyl moiety fromUDP-glucose to a nonreducing end of a glycogenmole-
cule, forming a-1,4-glycosidic linkages concurrent with the release of UDP.
Branches are formed by branching enzyme by cleaving an a-1,4-glycosidic
linkage, excising a segment of existing oligosaccharide, and reforming an
a-1,6 linkage. During synthesis, glycogen synthase adds the b-phosphate of
UDP-glucose to the 20 and 30 hydroxyl groups of glucose at the rate of approx-
imately one phosphate every 10,000 glucose residues. In this rare reaction,
UMP is released. These phosphate residues are subsequently removed by
the phosphatase laforin.
Cell Metabolism
Previewsexperiments, the authors
determined that the phos-
phate present in muscle
glycogen was attached to
the C2 and C3 carbons of the
glucose residues as monoes-
ters (Figure 1). There was no
evidence for phosphodiester
linkages or a C6 phosphomo-
noester as had been previ-
ously postulated. In addition,
since laforin was able to re-
move the phosphate from
these phospho-oligosaccha-
rides, these results provide
the first characterization of la-
forin’s substrate selectivity in
that laforin can hydrolyze C2
and C3 phosphomonoesters
with a minimum requirement
of a trisaccharide for activity.
Of the three questions
posed above, only ‘‘why’’ the
phosphate occurs in glycogen
remains. The authors point out
that the synthesis of other
biopolymers such as DNA or
RNA is carefully monitored
for misincorporation of bases
that results from polymerase
error. Indeed, the cell hasacquired specialized repair systems that
improve the fidelity of DNA and RNA poly-
merases. Likewise, incorporation of phos-
phate into glycogen could result from an
‘‘error’’ of glycogen synthase with laforin
servingas the repair enzyme. It is important
to note that the rate of phosphate incorpo-
ration into glycogen (104) is in the same
range as the error rates for proofreading
deficient DNA polymerases (103–106).
Alternatively, the C2 and C3 phosphates
in glycogen could reflect an aspect of
glycogenmetabolismyet tobediscovered.
Whatever the case, it is clear that laforin is234 Cell Metabolism 13, March 2, 2011 ª201capable of removing these phosphate
monoesters from glycogen and that when
laforin’s activity is lost, glycogen structure
is compromised, resulting in insoluable LB.
Even though the molecular etiology of
Lafora disease is becoming increasing
clear, what do these results suggest for
the treatment of Lafora disease, a fatal
disease forwhich there is noeffective ther-
apeutic treatment? The authors point out
thatMGSKOmice that lackbrain glycogen
appear to be normal, exercise as well as
wild-typemice, andarecapableof utilizing
glucose while displaying no neurological1 Elsevier Inc.symptoms (Pederson et al.,
2005). They suggest that
inhibition of brain glycogen
synthase, which would pre-
sumably preclude LB forma-
tion in neurons, ‘‘might pro-
vide a viable therapeutic
intervention’’ for this rare but
devastating disease.REFERENCES
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